Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. HSPT
HSPT logo

HSPT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
8.990
Open
8.885
VWAP
8.65
Vol
2.83K
Mkt Cap
77.18M
Low
8.475
Amount
24.45K
EV/EBITDA(TTM)
--
Total Shares
9.08M
EV
82.41M
EV/OCF(TTM)
--
P/S(TTM)
--
Horizon Space Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region. It has not selected any target business for its initial business combination. The Company has neither engaged in any operations nor generated any revenues.
Show More

Events Timeline

(ET)
2026-02-24
09:40:00
Horizon Space Acquisition II Corp Trading Halted
select
2026-02-13 (ET)
2026-02-13
12:10:00
Horizon Space Acquisition II Corp Trading Halted
select
2026-02-10 (ET)
2026-02-10
09:40:00
Horizon Space Acquisition II Corp Trading Halted Due to Volatility Trading Pause
select
2026-01-14 (ET)
2026-01-14
08:50:00
SL BIO and Horizon Space Merger Approved by SEC
select
2025-05-12 (ET)
2025-05-12
08:58:39
Horizon Space Acquisition II enters combination agreement with SL Bio
select

News

Newsfilter
8.5
02-03Newsfilter
Horizon Space Acquisition II Corp. Updates on SL BIO Business Combination Process
  • Redemption Process Clarification: HSPT has clarified the redemption process for shareholders regarding the business combination with SL BIO, requiring instructions to the transfer agent by 5 PM ET on February 11, 2026, to ensure shares are redeemed if the business combination or extension proposals are implemented.
  • Meeting Confirmation: The business combination meeting is scheduled for 9 AM on February 12, 2026, with a redemption deadline of 5 PM on February 10, ensuring shareholders can participate in voting at the Robinson & Cole LLP office in New York.
  • Shareholder Voting Rights: Shareholders as of the record date of December 29, 2025, retain voting rights even if shares are sold afterward, encouraging those who have not yet voted to act promptly to ensure their voices are heard.
  • Risk Advisory: The company warns shareholders of potential risks, including the possibility of the merger not closing, emphasizing the importance of reviewing relevant documents to understand all details and implications of the merger.
Newsfilter
8.5
01-14Newsfilter
SL BIO and HSPT Merger Approved by SEC, Expected Nasdaq Listing
  • Merger Progress: The registration statement for the merger between SL BIO and HSPT was approved by the SEC on January 13, 2026, marking a significant step towards SL BIO becoming a public company, which is expected to enhance its financing capabilities and market influence.
  • Shareholder Meeting Scheduled: HSPT plans to hold a special shareholder meeting on February 3, 2026, to vote on the merger proposal, which, if approved, will pave the way for SL BIO's listing and further strengthen its competitive position in the biomedicine sector.
  • New Company Structure: Post-merger, SL Science Holding Limited will become the new holding company, expected to be listed on Nasdaq under the ticker symbol “SLBT,” providing SL BIO with broader access to capital markets to support its R&D and market expansion.
  • Innovative Technology Potential: SL BIO focuses on developing cellular and gene therapies using immune stem cells and bovine-derived milk exosomes, which are anticipated to drive breakthroughs in regenerative medicine and cancer treatment, presenting significant market prospects and strategic importance.
Benzinga
9.0
01-09Benzinga
Saks Global Enterprises Faces Bankruptcy Risk, Seeks Capital Injection to Stay Afloat
  • Financial Crisis: Barely a year after acquiring Neiman Marcus for $2.65 billion, Saks Global Enterprises is facing potential bankruptcy, with lenders discussing capital injections to keep the luxury department store empire operational.
  • Supply Chain Issues: Vendors have begun slowing shipments due to Saks falling behind on payments, and the company’s request to extend overdue bills over a year has negatively impacted its reputation as a luxury retailer.
  • Acquisition Risks: Moody's has flagged the acquisition loans as highly risky, expressing doubts about the combined company's viability, which reflects market concerns regarding its future performance.
  • Strategic Challenges: Although the plan was to revive Saks and its brands through cost-cutting and tech upgrades, the actual execution has faced a crisis of trust with suppliers, potentially hindering future business recovery.
Benzinga
8.5
01-09Benzinga
SL Bio to Merge with Horizon Space Acquisition II at $5.7 Billion Valuation, Plans 2026 Listing
  • Merger Overview: Taiwan-based SL Bio Ltd. has entered into a merger agreement with Horizon Space Acquisition II Corp, with an implied equity valuation of approximately $5.7 billion, marking a strategic shift for the company to enter the U.S. market via SPAC.
  • Listing Path Preference: This merger reflects the biotechnology sector's preference for SPAC transactions, particularly as traditional IPOs face challenges, enabling SL Bio to secure long-term capital and enhance market visibility.
  • Focus on R&D: SL Bio is concentrating on advanced cellular and gene therapy technologies, developing immunotherapies for high-need oncology indications such as blood cancers, pancreatic cancer, and brain tumors, showcasing its market potential in critical therapeutic areas.
  • Future Outlook: The combined entity is expected to go public in early 2026, and if successful, will provide U.S. investors with direct exposure to SL Bio, further enhancing its influence in the biotechnology sector.
SeekingAlpha
8.5
2025-05-12SeekingAlpha
Horizon Space Acquisition II announces business combination agreement with SL Bio
  • Business Combination Announcement: Horizon Space Acquisition II Corp. has entered into a definitive business combination agreement with SL Bio, a biomedical company focused on cellular and gene therapies for skin care and cancer recovery.

  • Leadership and Timeline: The combined entity, to be named SL Science Holding Limited, is expected to be listed on Nasdaq by late 2025, with William Wang as CEO, Johnson Lau as CFO, and Ethan Shen as CTO.

Valuation Metrics

The current forward P/E ratio for Horizon Space Acquisition II Corp (HSPT.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Horizon Space Acquisition II Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.13
Current PS
0.00
Overvalued PS
1.27
Undervalued PS
-1.01

Financials

AI Analysis
Annual
Quarterly

Whales Holding HSPT

W
W. R. Berkley Corporation
Holding
HSPT
+8.39%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Horizon Space Acquisition II Corp (HSPT) stock price today?

The current price of HSPT is 8.5 USD — it has decreased -6.08

What is Horizon Space Acquisition II Corp (HSPT)'s business?

Horizon Space Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region. It has not selected any target business for its initial business combination. The Company has neither engaged in any operations nor generated any revenues.

What is the price predicton of HSPT Stock?

Wall Street analysts forecast HSPT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSPT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Horizon Space Acquisition II Corp (HSPT)'s revenue for the last quarter?

Horizon Space Acquisition II Corp revenue for the last quarter amounts to -124.52K USD, increased 270.56

What is Horizon Space Acquisition II Corp (HSPT)'s earnings per share (EPS) for the last quarter?

Horizon Space Acquisition II Corp. EPS for the last quarter amounts to USD, decreased

How many employees does Horizon Space Acquisition II Corp (HSPT). have?

Horizon Space Acquisition II Corp (HSPT) has 0 emplpoyees as of March 12 2026.

What is Horizon Space Acquisition II Corp (HSPT) market cap?

Today HSPT has the market capitalization of 77.18M USD.